Fierce Biotech article highlights dearth of inclusion in

An important article from industry publication Fierce Biotech highlights the lack of inclusion of the Down syndrome community in Alzheimer’s research. LuMind

Optimizing the manufacturing and antitumour response of CAR T therapy

Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine

Increasing clinical trial diversity

Fierce Biotech's 2022 Fierce 15

Executive Interviews at Fierce Biotech Summit 2022

DigitalHealthReadingList - June 16th

Clinical trials can make anyone a hero

Fierce Healthcare's 2023 Women of Influence

Diversity, Equity & Inclusion at Kite a Key Facet of Frederick Manufacturing Site's Work Culture

Advancing Site-Sponsor Relationships